Icu Medical Inc  (ICUI)
Other Ticker:  
Price: $84.6400 $0.02 0.024%
Day's High: $87.58 Week Perf: 0.5 %
Day's Low: $ 84.64 30 Day Perf: -14.01 %
Volume (M): 5,005 52 Wk High: $ 212.43
Volume (M$): $ 423,606 52 Wk Avg: $155.63
Open: $84.91 52 Wk Low: $78.28

 Market Capitalization (Millions $) 2,063
 Shares Outstanding (Millions) 24
 Employees 7,591
 Revenues (TTM) (Millions $) 2,248
 Net Income (TTM) (Millions $) 86
 Cash Flow (TTM) (Millions $) -356
 Capital Exp. (TTM) (Millions $) 161

Icu Medical Inc
ICU Medical Inc. is a global medical device company that specializes in designing, manufacturing, and selling a broad range of products for critical care and infusion therapy applications. The company was founded in 1984 by Dr. George Lopez and is headquartered in San Clemente, California.

ICU Medical produces a wide range of medical equipment for the healthcare industry, including needle-free systems, closed system transfer devices, catheters, and other accessories that are used in hospitals, clinics, and other healthcare facilities worldwide. The company's product portfolio is focused on intravenous (IV) infusion and critical care therapy, with a particular emphasis on medication delivery systems.

ICU Medical's products are designed to help reduce the risk of infection, contamination, and medication errors, while also improving patient safety, comfort, and convenience. The company's products are used in a variety of medical settings, including operating rooms, intensive care units, emergency departments, and ambulatory care centers.

One of ICU Medical's most innovative products is the "Clave" needle-free injection system, which was first introduced in 2000. The Clave system enables healthcare professionals to safely administer medications, fluids, and blood products to patients without the use of a needle, reducing the risk of needlestick injuries and infection. The Clave system is now used in hospitals and healthcare facilities worldwide and has become a standard of care in many healthcare settings.

Another key product offering from ICU Medical is the ChemoClave system, a closed system transfer device that allows for safe handling of hazardous drugs during chemotherapy infusion. This system helps to protect healthcare workers from exposure to potentially harmful substances, while also reducing the risk of contamination and environmental exposure.

In addition to its core product offerings, ICU Medical also offers a range of complementary services, including clinical education and training, technical support, and consulting services. The company's customer base includes a wide range of healthcare providers, including hospitals, ambulatory care centers, dialysis centers, and infusion therapy providers.

ICU Medical is committed to innovation, quality, and safety, and has received numerous certifications, awards, and recognition for its products and services. The company is focused on continuing to develop and improve its product offerings to help healthcare providers deliver the highest quality care to their patients.

   Company Address: 951 Calle Amanecer San Clemente 92673 CA
   Company Phone Number: 366-2183   Stock Exchange / Ticker: NASDAQ ICUI
   ICUI is expected to report next financial results on February 26, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Pavmed Inc

Pavmed Inc has failed to break-even despite the epic Surge in revenue in the financial time-frame ending September 30 2023

Pavmed Inc announced very solid Revenue improvement of 1103.947 % year on year to $0.92 million in the third quarter of 2023 earnings season, but lost money at $-0.16. Medical Equipment and Supplies company's business grew faster in contrast to the the revenue at nearly all of the Medical Equipment and Supplies industry contemporaries, in the third quarter of 2023 the two third entities in Medical Equipment and Supplies industries saw an average business improvement of 5.23% from the comparable reporting period a year ago.

Beyond Air Inc

The Medical Equipment and Supplies company announced Revenue of $0.239 million, in the July to September 30 2023

XAIR proclaimed $0.239 million, in Revenue in the financial period ending September 30 2023.

Sintx Technologies Inc

The company disclosed a quick revenue increase , in the financial span closing Sep 30 2023

For the third quarter of 2023 earnings season Sintx Technologies Inc increased a deficit per share of $-0.81 per share compare to $-0.11 a year prior and surged deficit from $-0.78 per share from the preceding reporting period. The revenue rose strongly by 59.155 % to $0.68 million from $0.43 million in the comparable reporting period a year prior and sequentially revenue surged by 33.465 % from $0.51 million. Medical Equipment and Supplies company's revenue, surge in the third quarter of 2023 compares advantageously to its Medical Equipment and Supplies sector contemporaries, which experienced all in all 5.23 % top-line elevation during the matching time yet.

Patterson Companies Inc

PDCO Reports Modest Revenue Rise, but Faces Steep Decline in Income in Latest Fiscal Period

Patterson Companies Inc, a leading player in the Medical Equipment and Supplies sector, recently released its financial results for the most recent fiscal period. Despite a modest revenue elevation of 1.588%, the company experienced a significant income contraction of -23.64% compared to the same quarter a year ago. This downturn in income can be attributed to various factors within the industry.
During the period in question, Patterson Companies Inc generated $1.65 billion in revenue and earnings per share (EPS) of $0.42. While these figures may seem promising, considering the growth in revenue and EPS, it is important to note that the company's performance lagged behind its sector peers. The Medical Equipment and Supplies sector witnessed a 5.93% rise in business during the second quarter of 2023, indicating that Patterson Companies Inc did not keep up with the industry's growth trajectory.

Embecta Corp

Embecta Corp Faces Significant Decline in Revenue During Fourth Quarter of 2023

Financial News Report:
Embecta Corp (NASDAQ: EMBC), a global diabetes care company, has reported a significant decline in income and profit for the July to September 2023 period. The company's income fell sharply by -92.65% to $0.10 per share compared to $1.42 per share in the same period last year. Additionally, profit plummeted by -59.89% from $0.26 per share in the prior quarter.
The revenue of Embecta Corp also went down sharply by -50.062% to $281.60 million from $563.90 million in the corresponding quarter a year prior. This is a sequential decrease of -1.366% from $285.50 million. In comparison, the rest of the Medical Equipment and Supplies sector posted a top-line growth in the fourth quarter of 2023.


Icu Medical Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com